Second International Consensus Conference on lesions of uncertain malignant potential in the breast (B3 lesions)

CJ Rageth, EAM O'Flynn, K Pinker… - Breast cancer research …, 2019 - Springer
Abstract Purpose The second International Consensus Conference on B3 lesions was held
in Zurich, Switzerland, in March 2018, organized by the International Breast Ultrasound …

AGO recommendations for the diagnosis and treatment of patients with early breast cancer: update 2022

N Ditsch, A Wöcke, M Untch, C Jackisch, US Albert… - Breast Care, 2022 - karger.com
Abstract Introduction: The AGO (Arbeitsgemeinschaft Gynäkologische Onkologie, German
Gynecological Oncology Group) Task Force on Diagnosis and Treatment of Breast Cancer …

High-risk lesions of the breast: concurrent diagnostic tools and management recommendations

F Catanzariti, D Avendano, G Cicero… - Insights into …, 2021 - Springer
Breast lesions with uncertain malignant behavior, also known as high-risk or B3 lesions, are
composed of a variety of pathologies with differing risks of associated malignancy. While …

[PDF][PDF] Arbeitsgemeinschaft Gynäkologische Onkologie recommendations for the diagnosis and treatment of patients with early breast cancer: update 2023

TW Park-Simon, V Müller, C Jackisch, US Albert… - Breast Care, 2023 - karger.com
Background: Each year the interdisciplinary Arbeitsgemeinschaft Gynäkologische Onkologie
(AGO), German Gynecological Oncology Group Breast Committee on Diagnosis and …

AGO recommendations for the diagnosis and treatment of patients with early breast cancer: update 2019

N Ditsch, M Untch, M Thill, V Müller, W Janni, US Albert… - Breast Care, 2019 - karger.com
For almost 20 years, the Breast Committee of the German Gynecological Oncology Group
(Arbeitsgemeinschaft Gynäkologische Onkologie, AGO) has been preparing and updating …

The incidence of adjacent synchronous invasive carcinoma and/or ductal carcinoma in situ in patients with intraductal papilloma without atypia on core biopsy: results …

F Nakhlis, GM Baker, M Pilewskie, R Gelman… - Annals of surgical …, 2021 - Springer
Background Available retrospective data suggest the upgrade rate for intraductal papilloma
(IP) without atypia on core biopsy (CB) ranges from 0 to 12%, leading to variation in …

AGO recommendations for the diagnosis and treatment of patients with early breast cancer: update 2021

N Ditsch, C Kolberg-Liedtke, M Friedrich, C Jackisch… - Breast Care, 2021 - karger.com
The Breast Committee of the Arbeitsgemeinschaft Gynäkologische Onkologie (German
Gynecological Oncology Group, AGO) presents the 2021 update of the evidence-based …

Treatment and outcome of 341 papillary breast lesions

P Chen, D Zhou, C Wang, G Ye, R Pan, L Zhu - World Journal of Surgery, 2019 - Springer
Background Papillary breast lesions constitute a pathological heterogeneous group and
display diverse clinical and imaging features. This study was conducted to analyze the …

Upgrade rate and predictive factors for breast benign intraductal papilloma diagnosed at biopsy: a meta-analysis

X Zhang, W Liu, T Hai, F Li - Annals of Surgical Oncology, 2021 - Springer
Background Current standard management for intraductal papilloma (IDP) diagnosed at
biopsy indicates complete surgical resection, but there are increasing controversies over …

Are we overtreating intraductal papillomas?

S Kiran, YJ Jeong, ME Nelson, A Ring… - Journal of Surgical …, 2018 - Elsevier
Background The management of intraductal papillomas (IDPs) diagnosed on core needle
biopsy (CNB) remains controversial regarding whether excision is required. We evaluated …